Merck’s Molnupiravir Set To Lead Forecast $6bn COVID-19 Oral Antiviral Market

Pfizer and Roche Also In The Running

 
• By Andrew McConaghie
Merck
Merck & Co and Ridgeback's antiviral is taken twice a day for 10 days, but must be administered within five days of mild-to-moderate symptoms emerging.

More from Business

More from Scrip